Flowers Foods Inc (FLO) stock
Close on Nov 12, 2026Market cap $1.27BP/E 42.9Yield 16.35%
Earnings
Flowers Foods's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Flowers Foods's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q3 FY2026ended Oct 4, 2026 | Nov 5, 2026Expected | – | – | – | – | – |
| Q2 FY2026ended Jul 18, 2026 | Aug 20, 2026after the close | $1.19B | -4.0% | $0.19 | $0.21 | Release |
| Q1 FY2026ended Apr 25, 2026 | May 21, 2026after the close | $1.57B | +1.2% | $0.20 | $0.29 | Release |
| Q4 FY2025ended Jan 3, 2026 | Feb 12, 2026after the close | $1.23B | +11.0% | -$0.32 | $0.22 | Release |
| Q3 FY2025ended Oct 4, 2025 | Nov 6, 2025after the close | $1.23B | +3.0% | $0.19 | $0.23 | Release |
| Q2 FY2025ended Jul 12, 2025 | Aug 15, 2025before the open | $1.24B | +1.5% | $0.28 | $0.30 | Release |
| Q1 FY2025ended Apr 19, 2025 | May 16, 2025before the open | $1.55B | -1.5% | $0.25 | $0.35 | Release |
| Q4 FY2024ended Dec 28, 2024 | Feb 7, 2025before the open | $1.11B | -1.6% | $0.20 | $0.22 | Release |
| Q3 FY2024ended Oct 5, 2024 | Nov 8, 2024before the open | $1.19B | -0.7% | $0.31 | $0.33 | Release |
| Q2 FY2024ended Jul 13, 2024 | Aug 16, 2024before the open | $1.23B | -0.2% | $0.32 | $0.36 | Release |
| Q1 FY2024ended Apr 20, 2024 | May 16, 2024after the close | $1.58B | +2.8% | $0.34 | $0.38 | Release |
| Q4 FY2023ended Dec 30, 2023 | Feb 9, 2024before the open | $1.13B | +4.2% | $0.17 | $0.20 | Release |
| Q3 FY2023ended Oct 7, 2023 | Nov 9, 2023after the close | $1.20B | +3.5% | -$0.22 | $0.29 | Release |
| Q2 FY2023ended Jul 15, 2023 | Aug 11, 2023before the open | $1.23B | +8.8% | $0.30 | $0.33 | Release |
| Q1 FY2023ended Apr 22, 2023 | May 19, 2023before the open | $1.53B | +6.8% | $0.33 | $0.38 | Release |
| Q4 FY2022ended Dec 31, 2022 | Feb 10, 2023before the open | $1.08B | +10.1% | $0.23 | $0.23 | Release |
| Q3 FY2022ended Oct 8, 2022 | Nov 10, 2022after the close | $1.16B | +12.6% | $0.19 | $0.30 | Release |
| Q2 FY2022ended Jul 16, 2022 | Aug 12, 2022before the open | $1.13B | – | $0.25 | $0.31 | Release |
| Q1 FY2022ended Apr 23, 2022 | May 20, 2022before the open | $1.44B | – | $0.40 | $0.44 | Release |
| Q4 FY2021ended Jan 1, 2022 | Feb 10, 2022after the close | $983.50M | – | $0.18 | $0.20 | Release |
| Q3 FY2021ended Oct 9, 2021 | Nov 12, 2021before the open | $1.03B | – | $0.18 | $0.30 | Release |
| Q2 FY2021ended Jul 17, 2021 | Aug 13, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Apr 24, 2021 | May 21, 2021before the open | – | – | – | – | Filing |
| Q4 FY2020ended Jan 2, 2021 | Feb 12, 2021before the open | – | – | – | – | Filing |
| Q3 FY2020ended Oct 3, 2020 | Nov 6, 2020before the open | – | – | – | – | Filing |
| Q2 FY2020ended Jul 11, 2020 | Jul 20, 2020after the close | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Flowers Foods's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Net sales | FY2026 | $5.07B – $5.14B | $5.16B – $5.27B | Lowered | Aug 20, 2026 |
| Net salesGAAP | FY2026 | $5.16B – $5.27B | – | New | Feb 12, 2026 |
| Net sales change compared to the prior year | FY2026 | -3.5% – -2.2% | -1.8% – +0.2% | Lowered | Aug 20, 2026 |
| Adjusted EBITDAnon-GAAP | FY2026 | $453.00M – $481.00M | $465.00M – $495.00M | Lowered | Aug 20, 2026 |
| Net income per diluted common shareGAAP | FY2026 | $0.64 – $0.74 | $0.71 – $0.81 | Lowered | Aug 20, 2026 |
| Adjusted diluted EPSnon-GAAP | FY2026 | $0.75 – $0.85 | $0.80 – $0.90 | Lowered | Aug 20, 2026 |
| Capital expenditures | FY2026 | $115.00M – $125.00M | $115.00M – $125.00M | Reaffirmed | Aug 20, 2026 |
| Depreciation and amortization | FY2026 | $165.00M – $170.00M | $165.00M – $170.00M | Raised | Aug 20, 2026 |
| effective tax rate | FY2026 | 26% | 26% | Reaffirmed | Aug 20, 2026 |
| Net interest expense | FY2026 | $65.00M – $70.00M | $65.00M – $70.00M | Lowered | Aug 20, 2026 |
| Weighted average diluted share count | FY2026 | 213.5 | 213.5 | Reaffirmed | Aug 20, 2026 |
Guidance vs results
The last range Flowers Foods gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2025 | Adjusted diluted EPS | $1.02 – $1.08 | $1.10Σ4Q | Above range |
| FY2025 | EPS (GAAP) | $0.85 – $0.91 | $0.40Σ4Q | Below range |
| FY2025 | Revenue | $5.25B – $5.31B | $5.26BΣ4Q | Within range |
| FY2025 | Revenue growth | +2.9% – +4% | +3%Σ4Q | Within range |
Guidance history
Every forecast Flowers Foods put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 20, 2026 | Capital expenditures | FY2026 | $115.00M – $125.00M | Reaffirmed |
| Aug 20, 2026 | Adjusted EBITDA | FY2026 | $453.00M – $481.00M | Lowered |
| Aug 20, 2026 | Adjusted diluted EPS | FY2026 | $0.75 – $0.85 | Lowered |
| Aug 20, 2026 | Net income per diluted common share | FY2026 | $0.64 – $0.74 | Lowered |
| Aug 20, 2026 | Weighted average diluted share count | FY2026 | 213.5 | Reaffirmed |
| Aug 20, 2026 | effective tax rate | FY2026 | 26% | Reaffirmed |
| Aug 20, 2026 | Depreciation and amortization | FY2026 | $165.00M – $170.00M | Raised |
| Aug 20, 2026 | Net interest expense | FY2026 | $65.00M – $70.00M | Lowered |
| Aug 20, 2026 | Net sales change compared to the prior year | FY2026 | -3.5% – -2.2% | Lowered |
| Aug 20, 2026 | Net sales | FY2026 | $5.07B – $5.14B | Lowered |
| May 21, 2026 | Capital expenditures | FY2026 | $115.00M – $125.00M | New |
| May 21, 2026 | Adjusted EBITDA | FY2026 | $465.00M – $495.00M | Reaffirmed |
| May 21, 2026 | Adjusted diluted EPS | FY2026 | $0.80 – $0.90 | Reaffirmed |
| May 21, 2026 | Net income per diluted common share | FY2026 | $0.71 – $0.81 | New |
| May 21, 2026 | Weighted average diluted share count | FY2026 | 213.5 | Reaffirmed |
| May 21, 2026 | effective tax rate | FY2026 | 26% | Reaffirmed |
| May 21, 2026 | Depreciation and amortization | FY2026 | $165.00M – $170.00M | Raised |
| May 21, 2026 | Net interest expense | FY2026 | $65.00M – $70.00M | Lowered |
| May 21, 2026 | Net sales change compared to the prior year | FY2026 | -1.8% – +0.2% | New |
| May 21, 2026 | Net sales | FY2026 | $5.16B – $5.27B | New |
| Feb 12, 2026 | Adjusted EBITDA | FY2026 | $465.00M – $495.00M | New |
| Feb 12, 2026 | Adjusted diluted EPS | FY2026 | $0.80 – $0.90 | New |
| Feb 12, 2026 | Weighted average diluted share count | FY2026 | 213.5 | New |
| Feb 12, 2026 | effective tax rate | FY2026 | 26% | New |
| Feb 12, 2026 | Depreciation and amortization | FY2026 | $165.00M – $170.00M | New |
| Feb 12, 2026 | Net interest expense | FY2026 | $65.00M – $70.00M | Lowered |
| Feb 12, 2026 | Net sales | FY2026 | $5.16B – $5.27B | New |
| Nov 6, 2025 | Capital expenditures | FY2025 | $120.00M – $130.00M | New |
| Nov 6, 2025 | Adjusted EBITDA | FY2025 | $515.00M – $532.00M | New |
| Nov 6, 2025 | Adjusted diluted EPS | FY2025 | $1.02 – $1.08 | New |
| Nov 6, 2025 | Net income per diluted common share | FY2025 | $0.85 – $0.91 | New |
| Nov 6, 2025 | Net sales growth | FY2025 | +2.9% – +4% | New |
| Nov 6, 2025 | Net sales | FY2025 | $5.25B – $5.31B | New |
| Aug 15, 2025 | Capital expenditures | FY2025 | $135.00M – $145.00M | Lowered |
| Aug 15, 2025 | Adjusted EBITDA | FY2025 | $512.00M – $538.00M | Lowered |
| Aug 15, 2025 | Adjusted diluted EPS | FY2025 | $1.00 – $1.10 | Lowered |
| Aug 15, 2025 | Net income per diluted common share | FY2025 | $0.88 – $0.98 | Lowered |
| Aug 15, 2025 | Net sales growth | FY2025 | +2.7% – +4% | Lowered |
| Aug 15, 2025 | Net sales | FY2025 | $5.24B – $5.31B | Lowered |
| May 16, 2025 | Capital expenditures | FY2025 | $140.00M – $150.00M | Reaffirmed |
| May 16, 2025 | Adjusted EBITDA | FY2025 | $534.00M – $562.00M | Lowered |
| May 16, 2025 | Adjusted diluted EPS | FY2025 | $1.05 – $1.15 | Lowered |
| May 16, 2025 | Net income per diluted common share | FY2025 | $0.95 – $1.05 | New |
| May 16, 2025 | effective tax rate | FY2025 | 25% | Reaffirmed |
| May 16, 2025 | Depreciation and amortization | FY2025 | $170.00M – $175.00M | Raised |
| May 16, 2025 | Net interest expense | FY2025 | $63.00M – $68.00M | Lowered |
| May 16, 2025 | Net sales | FY2025 | $5.30B – $5.40B | Lowered |
| Feb 7, 2025 | Capital expenditures | FY2025 | $140.00M – $150.00M | New |
| Feb 7, 2025 | Adjusted EBITDA | FY2025 | $560.00M – $591.00M | New |
| Feb 7, 2025 | Adjusted diluted EPS | FY2025 | $1.11 – $1.24 | New |
| Feb 7, 2025 | diluted share count | FY2025 | 212.3 | New |
| Feb 7, 2025 | effective tax rate | FY2025 | 25% | New |
| Feb 7, 2025 | Depreciation and amortization | FY2025 | $175.00M – $185.00M | New |
| Feb 7, 2025 | Net interest expense | FY2025 | $60.00M – $65.00M | Lowered |
| Feb 7, 2025 | Net sales growth | FY2025 | +5.9% – +7.5% | New |
| Feb 7, 2025 | Net sales | FY2025 | $5.40B – $5.49B | New |
| Nov 8, 2024 | Capital expenditures | FY2024 | $130.00M – $140.00M | Lowered |
| Nov 8, 2024 | Capital expenditures related to the ERP upgrade | FY2024 | $5.00M – $7.00M | Lowered |
| Nov 8, 2024 | Adjusted EBITDA | FY2024 | $530.00M – $542.00M | Narrowed |
| Nov 8, 2024 | Adjusted diluted EPS | FY2024 | $1.24 – $1.28 | Narrowed |
| Nov 8, 2024 | Net income per diluted common share | FY2024 | $1.15 – $1.19 | Narrowed |
| Nov 8, 2024 | Weighted average diluted share count | FY2024 | 212.5 | Reaffirmed |
| Nov 8, 2024 | effective tax rate | FY2024 | 25% | Reaffirmed |
| Nov 8, 2024 | Depreciation and amortization | FY2024 | $155.00M – $160.00M | Raised |
| Nov 8, 2024 | Net interest expense | FY2024 | $20.00M – $24.00M | Lowered |
| Nov 8, 2024 | Net sales growth | FY2024 | +0.5% – +1.1% | New |
| Nov 8, 2024 | Net sales | FY2024 | $5.12B – $5.15B | Narrowed |
| Aug 16, 2024 | Capital expenditures | FY2024 | $145.00M – $155.00M | Reaffirmed |
| Aug 16, 2024 | Adjusted EBITDA | FY2024 | $524.00M – $553.00M | Reaffirmed |
| Aug 16, 2024 | Adjusted diluted EPS | FY2024 | $1.20 – $1.30 | Reaffirmed |
| Aug 16, 2024 | Net income per diluted common share | FY2024 | $1.12 – $1.22 | Lowered |
| Aug 16, 2024 | Weighted average diluted share count | FY2024 | 212.5 | Lowered |
| Aug 16, 2024 | effective tax rate | FY2024 | 25% | Reaffirmed |
| Aug 16, 2024 | Depreciation and amortization | FY2024 | $155.00M – $160.00M | Raised |
| Aug 16, 2024 | Net interest expense | FY2024 | $20.00M – $24.00M | Lowered |
| Aug 16, 2024 | Sales | FY2024 | $5.09B – $5.17B | Reaffirmed |
| May 16, 2024 | Capital expenditures | FY2024 | $145.00M – $155.00M | New |
| May 16, 2024 | Adjusted EBITDA | FY2024 | $524.00M – $553.00M | Reaffirmed |
| May 16, 2024 | Adjusted diluted EPS | FY2024 | $1.20 – $1.30 | Reaffirmed |
| May 16, 2024 | Net income per diluted common share | FY2024 | $1.16 – $1.26 | New |
| May 16, 2024 | Weighted average diluted share count | FY2024 | 213 | New |
| May 16, 2024 | effective tax rate | FY2024 | 25% | New |
| May 16, 2024 | Depreciation and amortization | FY2024 | $160.00M – $165.00M | New |
| May 16, 2024 | Net interest expense | FY2024 | $22.00M – $26.00M | Lowered |
| May 16, 2024 | Sales | FY2024 | $5.09B – $5.17B | New |
| Feb 9, 2024 | Capital expenditures | FY2024 | $120.00M – $130.00M | New |
| Feb 9, 2024 | Adjusted EBITDA | FY2024 | $524.00M – $553.00M | New |
| Feb 9, 2024 | Adjusted diluted EPS | FY2024 | $1.20 – $1.30 | New |
| Feb 9, 2024 | Weighted average diluted share count | FY2024 | 213 | New |
| Feb 9, 2024 | effective tax rate | FY2024 | 25% | New |
| Feb 9, 2024 | Depreciation and amortization | FY2024 | $160.00M – $165.00M | New |
| Feb 9, 2024 | Net interest expense | FY2024 | $22.00M – $26.00M | Lowered |
| Feb 9, 2024 | Sales | FY2024 | $5.09B – $5.17B | New |
| Nov 9, 2023 | Capital expenditures | FY2023 | $135.00M – $145.00M | Lowered |
| Nov 9, 2023 | Adjusted EBITDA | FY2023 | $495.00M – $515.00M | Lowered |
| Nov 9, 2023 | Adjusted diluted EPS | FY2023 | $1.18 – $1.25 | Reaffirmed |
| Nov 9, 2023 | Diluted EPS | FY2023 | $0.60 – $0.67 | Lowered |
| Nov 9, 2023 | Weighted average diluted share count | FY2023 | 213 | Reaffirmed |
| Nov 9, 2023 | effective tax rate | FY2023 | 24% | Reaffirmed |
| Nov 9, 2023 | Depreciation and amortization | FY2023 | $150.00M – $155.00M | Raised |
| Nov 9, 2023 | Net interest expense | FY2023 | $16.00M – $18.00M | Lowered |
| Nov 9, 2023 | Sales | FY2023 | $5.09B – $5.10B | Lowered |
| Aug 11, 2023 | Capital expenditures | FY2023 | $145.00M – $155.00M | Raised |
| Aug 11, 2023 | Adjusted EBITDA | FY2023 | $503.00M – $528.00M | Raised |
| Aug 11, 2023 | Adjusted diluted EPS | FY2023 | $1.18 – $1.25 | Raised |
| Aug 11, 2023 | Net income per diluted common share | FY2023 | $1.10 – $1.17 | Lowered |
| Aug 11, 2023 | Weighted average diluted share count | FY2023 | 213 | Reaffirmed |
| Aug 11, 2023 | effective tax rate | FY2023 | 24% | Lowered |
| Aug 11, 2023 | Depreciation and amortization | FY2023 | $155.00M – $160.00M | Raised |
| Aug 11, 2023 | Net interest expense | FY2023 | $16.00M – $18.00M | Lowered |
| Aug 11, 2023 | Sales | FY2023 | $5.10B – $5.14B | Raised |
| May 19, 2023 | Capital expenditures | FY2023 | $140.00M – $150.00M | New |
| May 19, 2023 | Adjusted EBITDA | FY2023 | $494.00M – $528.00M | Lowered |
| May 19, 2023 | Adjusted EPS | FY2023 | $1.15 – $1.25 | Lowered |
| May 19, 2023 | Net income per diluted common share | FY2023 | $1.11 – $1.21 | New |
| May 19, 2023 | Weighted average diluted share count | FY2023 | 213 | New |
| May 19, 2023 | effective tax rate | FY2023 | 25% | New |
| May 19, 2023 | Depreciation and amortization | FY2023 | $160.00M – $165.00M | New |
| May 19, 2023 | Net interest expense | FY2023 | $9.00M – $13.00M | Lowered |
| May 19, 2023 | Sales | FY2023 | $5.09B – $5.14B | New |
| Feb 10, 2023 | Capital expenditures | FY2023 | $140.00M – $150.00M | New |
| Feb 10, 2023 | Adjusted EBITDA | FY2023 | $513.00M – $543.00M | New |
| Feb 10, 2023 | Adjusted EPS | FY2023 | $1.20 – $1.30 | New |
| Feb 10, 2023 | Weighted average diluted share count | FY2023 | 213 | New |
| Feb 10, 2023 | effective tax rate | FY2023 | 25% | New |
| Feb 10, 2023 | Depreciation and amortization | FY2023 | $160.00M – $165.00M | New |
| Feb 10, 2023 | Net interest expense | FY2023 | $8.00M – $12.00M | Lowered |
| Feb 10, 2023 | Sales | FY2023 | $5.18B – $5.24B | New |
| Nov 10, 2022 | Capital expenditures | FY2022 | $150.00M – $160.00M | Reaffirmed |
| Nov 10, 2022 | Adjusted EPS | FY2022 | $1.25 – $1.30 | Reaffirmed |
| Nov 10, 2022 | Net income per diluted common share | FY2022 | $1.04 – $1.09 | Lowered |
| Nov 10, 2022 | Weighted average diluted share count | FY2022 | 213.5 | Reaffirmed |
| Nov 10, 2022 | effective tax rate | FY2022 | 24% – 24.5% | Reaffirmed |
| Nov 10, 2022 | Depreciation and amortization | FY2022 | $140.00M – $145.00M | Raised |
| Nov 10, 2022 | Net interest expense | FY2022 | $7.00M | Lowered |
| Nov 10, 2022 | Sales | FY2022 | $4.81B – $4.85B | Raised |
| Aug 12, 2022 | Capital expenditures | FY2022 | $150.00M – $160.00M | Reaffirmed |
| Aug 12, 2022 | Adjusted EPS | FY2022 | $1.25 – $1.30 | Raised |
| Aug 12, 2022 | Net income per diluted common share | FY2022 | $1.16 – $1.21 | Lowered |
| Aug 12, 2022 | Weighted average diluted share count | FY2022 | 213.5 | Reaffirmed |
| Aug 12, 2022 | effective tax rate | FY2022 | 24% – 24.5% | Reaffirmed |
| Aug 12, 2022 | Depreciation and amortization | FY2022 | $135.00M – $145.00M | New |
| Aug 12, 2022 | Net interest expense | FY2022 | $7.00M | Lowered |
| Aug 12, 2022 | Sales | FY2022 | $4.76B – $4.85B | New |
| May 20, 2022 | Capital expenditures | FY2022 | $150.00M – $160.00M | Lowered |
| May 20, 2022 | Adjusted EPS | FY2022 | $1.20 – $1.30 | Lowered |
| May 20, 2022 | Net income per diluted common share | FY2022 | $1.17 – $1.27 | New |
| May 20, 2022 | Weighted average diluted share count | FY2022 | 213.5 | Reaffirmed |
| May 20, 2022 | effective tax rate | FY2022 | 24% – 24.5% | Lowered |
| May 20, 2022 | Depreciation and amortization | FY2022 | $135.00M – $145.00M | Raised |
| May 20, 2022 | Net interest expense | FY2022 | $7.00M | Lowered |
| May 20, 2022 | Sales | FY2022 | $4.76B – $4.85B | Raised |
| Feb 10, 2022 | Capital expenditures | FY2022 | $175.00M – $185.00M | New |
| Feb 10, 2022 | Adjusted EPS | FY2022 | $1.25 – $1.35 | New |
| Feb 10, 2022 | Weighted average diluted share count | FY2022 | 213.5 | New |
| Feb 10, 2022 | effective tax rate | FY2022 | 24.5% – 25% | New |
| Feb 10, 2022 | Depreciation and amortization | FY2022 | $135.00M – $145.00M | New |
| Feb 10, 2022 | Net interest expense | FY2022 | $7.00M | Lowered |
| Feb 10, 2022 | Sales | FY2022 | $4.66B – $4.70B | New |
| Nov 12, 2021 | Capital expenditures | FY2021 | $125.00M – $135.00M | New |
| Nov 12, 2021 | Diluted EPS | FY2021 | $1.22 – $1.26 | New |
| Nov 12, 2021 | Net income per diluted common share | FY2021 | $0.96 – $1.00 | New |
| Nov 12, 2021 | Weighted average diluted share count | FY2021 | 213 | New |
| Nov 12, 2021 | effective tax rate | FY2021 | 24.5% | New |
| Nov 12, 2021 | Depreciation and amortization | FY2021 | $135.00M – $140.00M | New |
| Nov 12, 2021 | Net interest expense | FY2021 | $8.00M | Lowered |
| Nov 12, 2021 | Sales | FY2021 | $4.30B – $4.34B | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Flowers Foods filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- News
- Results
- Update
- Update
- Results
- Results
- Results
- Results
See a number that looks wrong?